Natco Pharma gains on launching generic version of Teriflunomide

05 Apr 2018 Evaluate

Natco Pharma is currently trading at Rs. 782.05, up by 14.35 points or 1.87% from its previous closing of Rs. 767.70 on the BSE.

The scrip opened at Rs. 782.10 and has touched a high and low of Rs. 789.45 and Rs. 780.00 respectively. So far 2,355 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1080.00 on 09-Jun-2017 and a 52 week low of Rs. 671.25 on 10-Aug-2017.

Last one week high and low of the scrip stood at Rs. 789.45 and Rs. 751.00 respectively. The current market cap of the company is Rs. 14,432.00 crore.

The promoters holding in the company stood at 48.36%, while Institutions and Non-Institutions held 30.15% and 21.49% respectively.

Natco Pharma is the first company in India to launch a generic version of Teriflunomide, for the treatment of Relapsing and Remitting forms of Multiple Sclerosis (RRMS), under its brand DENOPSY. This is the first oral medicine for RRMS being offered in India at two different strengths- 14 mg & 7 mg tablets. Teriflunomide is sold by Sanofi-Genzyme under brand name of AUBAGIO, in the USA market.

DENOPSY is priced attractively & much lower than other alternate options in India. As per WHO 2013 estimates, the number of patients suffering from Multiple Sclerosis in India is 5-20 per 1 lakh population.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.


Natco Pharma Share Price

888.60 -14.95 (-1.65%)
01-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.40
Dr. Reddys Lab 1253.60
Cipla 1500.10
Zydus Lifesciences 914.50
Lupin 2103.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×